Fintel reports that on March 4, 2025, Citigroup downgraded their outlook for Tandem Diabetes Care (LSE:0M0F) from Buy to Neutral. There are 601 funds or institutions reporting positions in Tandem ...

Citigroup accidentally credited a customer account $81 trillion instead of $280 last April. It took three employees and several hours to realize and correct the error ...

Citigroup reiterated their sell rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report report published on Thursday,Benzinga reports. They currently have a $27.00 price ...

GE HealthCare Technologies (NASDAQ:GEHC – Free Report) had its target price upped by Citigroup from $103.00 ... Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report). The ...

Sabra Health Care REIT, Inc. (Nasdaq ... the company’s Executive Vice President of Finance, will attend Citi’s 2025 Global Property CEO Conference on March 3-5, 2025 at The Diplomat Beach ...

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, ...